Nasdaq Achl News Today

Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […]

Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is set to announce its earnings results on Tuesday, April 2nd. Achilles Therapeutics Stock Performance Shares of NASDAQ ACHL opened at $1.25 on Monday. The business has a fifty day simple moving average of $1.14 and a 200 day simple moving average of $0.96. The company has a […]

Bank of America reaffirmed their underperform rating on shares of Achilles Therapeutics (NASDAQ:ACHL – Free Report) in a report released on Thursday morning, Benzinga reports. Achilles Therapeutics Stock Up 1.2 % Shares of Achilles Therapeutics stock opened at $0.87 on Thursday. The firm’s 50 day moving average price is $0.86 and its 200-day moving average […]

Achilles Therapeutics (NASDAQ:ACHL – Get Free Report)‘s stock had its “underperform” rating reaffirmed by investment analysts at Bank of America in a research note issued to investors on Thursday, Benzinga reports. Achilles Therapeutics Trading Down 7.6 % Shares of NASDAQ:ACHL traded down $0.07 during midday trading on Thursday, hitting $0.89. 209,674 shares of the stock […]

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report)’s stock price shot up 1.8% during trading on Monday . The company traded as high as $0.85 and last traded at $0.84. 151,863 shares changed hands during trading, a decline of 10% from the average session volume of 167,858 shares. The stock had previously closed at $0.82. […]

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) shares shot up 1.8% on Monday . The company traded as high as $0.85 and last traded at $0.84. 151,863 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 167,858 shares. The stock had previously closed at $0.82. Wall Street […]

Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is scheduled to be issuing its quarterly earnings data on Monday, November 6th. Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) last posted its quarterly earnings data on Friday, August 4th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.02). […]

Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 14,800 shares, a growth of 114.5% from the April 30th total of 6,900 shares. Approximately 0.0% of the company’s shares are sold short. Based […]

- Phase I/IIa clinical trials in NSCLC and melanoma progressing with additional clinical and translational science data expected in the fourth quarter of...

Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company’s operations are not affected by the receipt of the...